Dow Down0.02% Nasdaq Up0.48%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
3.20 Up 0.10(3.06%) 1:58PM EST - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue -   147   7,584  
Cost of Revenue -   -   -  
Gross Profit -   147   7,584  
Operating Expenses
Research Development71,860  49,412  41,464  
Selling General and Administrative15,699  11,676  11,552  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (87,559) (60,941) (45,432)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes(87,559)(60,941)(45,432)
Interest Expense2,633  1,849  1,948  
Income Before Tax(90,192)(62,790)(47,380)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(90,192)(62,790)(47,380)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (90,192) (62,790) (47,380)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (90,192) (62,790) (47,380)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.